Enrique Sánchez-Lemus

Angiotensin II AT1 Receptor Blockade Ameliorates Brain Inflammation

Július Benický, Enrique Sánchez-Lemus, Masaru Honda et al. · Neuropsychopharmacology · 2010 · 256 citations · Full text

Inflammation, Medicine, Neuropharmacology +7

Candesartan, an Angiotensin II AT1-Receptor Blocker and PPAR-γ Agonist, Reduces Lesion Volume and Improves Motor and Memory Function After Traumatic Brain Injury in Mice

Sonia Villapol, Alexandra K. Yaszemski, Trevor T. Logan et al. · Neuropsychopharmacology · 2012 · 120 citations · Full text

Inflammation, Traumatic Brain Injury, Medicine +12

Six Commercially Available Angiotensin II AT1 Receptor Antibodies are Non-specific

Július Benický, Roman Hafko, Enrique Sánchez-Lemus et al. · Cellular and Molecular Neurobiology · 2012 · 114 citations · Full text

Molecular Pharmacology, Medicine, Immunology +2

Telmisartan ameliorates glutamate-induced neurotoxicity: Roles of AT1 receptor blockade and PPARγ activation

Juan Wang, Tao Pang, Roman Hafko et al. · Neuropharmacology · 2013 · 111 citations

Molecular Pharmacology, Synaptic Signaling, Medicine +10

A Centrally Acting, Anxiolytic Angiotensin II AT1 Receptor Antagonist Prevents the Isolation Stress-Induced Decrease in Cortical CRF1 Receptor and Benzodiazepine Binding

Juan M. Saavedra, Inés Armando, Claudia Bregonzio et al. · Neuropsychopharmacology · 2005 · 108 citations · Full text

Cortical Crf1 Receptor, Neurophysiology, Medicine +10